التفاصيل البيبلوغرافية
| العنوان: |
#1015 Mirvetuximab soravtansine demonstrates longer overall survival and progression-free survival by prior lines of therapy vs chemotherapy in platinum-resistant ovarian cancer and high folate receptor alpha expression in the MIRASOL trial |
| المؤلفون: |
Gorp, Toon Van, Sabatier, Renaud, Konecny, Gottfried E, Gordon, Jayson, Pignata, Sandro, Colombo, Nicoletta, Moroney, John, Martin, Lainie P, Lee, Jung-Yun, Roszak, Andrzej, Breuer, Shani, Boere, Ingrid, Tredan, Olivier, Provencher, Diane, Farrelly, Laura, Leath, Trey, Wang, Yuemei, Method, Michael, Lorusso, Domenica, Moore, Kathleen N |
| المصدر: |
Oral Sessions |
| بيانات النشر: |
BMJ Publishing Group Ltd |
| سنة النشر: |
2023 |
| نوع الوثيقة: |
conference object |
| اللغة: |
unknown |
| DOI: |
10.1136/ijgc-2023-esgo.44 |
| DOI: |
10.1136/ijgc-2023-ESGO.44 |
| الإتاحة: |
https://doi.org/10.1136/ijgc-2023-esgo.44Test |
| رقم الانضمام: |
edsbas.AED15020 |
| قاعدة البيانات: |
BASE |
